Therefore, the in situ albumin-bound Al-ProD greatly enhances tumor accumulation with prolonged in vivo half-life and induces a potent antitumor efficacy by selectively releasing free DOX in cathepsin B-overexpressed tumor cells (Figure 1c). The gene discussed is CTSB; the disease is neoplasm.